Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series (vol 58, pg 510, 2020)

被引：0
作者：
Nakamura, Hideta
Miyagi, Kazuya
Otsuki, Mariko
Higure, Yuuri
Nishiyama, Naoya
Kinjo, Takeshi
Nakamatsu, Masashi
Haranaga, Shusaku
Tateyama, Masao
Fujita, Jiro
机构：
来源：
RESPIRATORY INVESTIGATION | 2021年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：708 / 708
页数：1
相关论文
共 1 条
  • [1] Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
    Nakamura, Hideta
    Miyagi, Kazuya
    Otsuki, Mariko
    Higure, Yuuri
    Nishiyama, Naoya
    Kinjo, Takeshi
    Nakamatsu, Masashi
    Haranaga, Shusaku
    Tateyama, Masao
    Fujita, Jiro
    [J]. RESPIRATORY INVESTIGATION, 2020, 58 (06) : 510 - 512
1